PDB Short entry for 4DBS HEADER OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR 16-JAN-12 4DBS TITLE CRYSTAL STRUCTURE OF HUMAN 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 5 TITLE 2 (AKR1C3) IN COMPLEX WITH NADP+ AND 3'-[(4-NITRONAPHTHALEN-1-YL) TITLE 3 AMINO]BENZOIC ACID COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALDO-KETO REDUCTASE FAMILY 1 MEMBER C3; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: 17-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 5, 17-BETA-HSD 5, COMPND 5 3-ALPHA-HSD TYPE II, 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE TYPE 2, 3- COMPND 6 ALPHA-HSD TYPE 2, CHLORDECONE REDUCTASE HOMOLOG HAKRB, DIHYDRODIOL COMPND 7 DEHYDROGENASE 3, DD-3, DD3, DIHYDRODIOL DEHYDROGENASE TYPE I, HA1753, COMPND 8 INDANOL DEHYDROGENASE, PROSTAGLANDIN F SYNTHASE, PGFS, TESTOSTERONE COMPND 9 17-BETA-DEHYDROGENASE 5, TRANS-1,2-DIHYDROBENZENE-1,2-DIOL COMPND 10 DEHYDROGENASE; COMPND 11 EC: 1.1.1.213, 1.1.1.112, 1.1.1.188, 1.1.1.63, 1.1.1.64, 1.3.1.20; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: C41(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET16B KEYWDS CASTRATE RESISTANT PROSTATE CANCER, AKR1C3 SELECTIVE INHIBITOR, TIM KEYWDS 2 BARREL, STEROID METABOLISM, OXIDOREDUCTASE-OXIDOREDUCTASE INHIBITOR KEYWDS 3 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.CHEN,D.W.CHRISTIANSON,J.D.WINKLER,T.M.PENNING REVDAT 6 13-SEP-23 4DBS 1 REMARK REVDAT 5 15-NOV-17 4DBS 1 REMARK REVDAT 4 23-MAY-12 4DBS 1 JRNL REVDAT 3 02-MAY-12 4DBS 1 JRNL REVDAT 2 11-APR-12 4DBS 1 REMARK TITLE REVDAT 1 28-MAR-12 4DBS 0 JRNL AUTH M.CHEN,A.O.ADENIJI,B.M.TWENTER,J.D.WINKLER,D.W.CHRISTIANSON, JRNL AUTH 2 T.M.PENNING JRNL TITL CRYSTAL STRUCTURES OF AKR1C3 CONTAINING AN JRNL TITL 2 N-(ARYL)AMINO-BENZOATE INHIBITOR AND A BIFUNCTIONAL AKR1C3 JRNL TITL 3 INHIBITOR AND ANDROGEN RECEPTOR ANTAGONIST. THERAPEUTIC JRNL TITL 4 LEADS FOR CASTRATE RESISTANT PROSTATE CANCER. JRNL REF BIOORG.MED.CHEM.LETT. V. 22 3492 2012 JRNL REFN ISSN 0960-894X JRNL PMID 22507964 JRNL DOI 10.1016/J.BMCL.2012.03.085 REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.5_2 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.20 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.160 REMARK 3 COMPLETENESS FOR RANGE (%) : 92.0 REMARK 3 NUMBER OF REFLECTIONS : 53065 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.183 REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.222 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.040 REMARK 3 FREE R VALUE TEST SET COUNT : 2676 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 40.2043 - 4.9379 1.00 2862 157 0.1438 0.1593 REMARK 3 2 4.9379 - 3.9204 1.00 2869 151 0.1412 0.1704 REMARK 3 3 3.9204 - 3.4252 1.00 2906 143 0.1702 0.2141 REMARK 3 4 3.4252 - 3.1121 1.00 2866 163 0.1888 0.2280 REMARK 3 5 3.1121 - 2.8891 0.99 2836 168 0.1945 0.2298 REMARK 3 6 2.8891 - 2.7188 0.98 2849 135 0.1887 0.2093 REMARK 3 7 2.7188 - 2.5827 0.97 2808 130 0.1862 0.2359 REMARK 3 8 2.5827 - 2.4703 0.96 2780 147 0.1918 0.2064 REMARK 3 9 2.4703 - 2.3752 0.96 2751 153 0.1893 0.2352 REMARK 3 10 2.3752 - 2.2933 0.95 2731 129 0.1837 0.2455 REMARK 3 11 2.2933 - 2.2216 0.93 2646 148 0.1913 0.3105 REMARK 3 12 2.2216 - 2.1581 0.92 2665 161 0.1979 0.2496 REMARK 3 13 2.1581 - 2.1012 0.90 2615 137 0.1961 0.2609 REMARK 3 14 2.1012 - 2.0500 0.90 2518 142 0.2036 0.2941 REMARK 3 15 2.0500 - 2.0034 0.87 2542 141 0.2226 0.2764 REMARK 3 16 2.0034 - 1.9608 0.85 2406 121 0.2240 0.2760 REMARK 3 17 1.9608 - 1.9215 0.83 2449 115 0.2396 0.3408 REMARK 3 18 1.9215 - 1.8853 0.80 2287 115 0.2456 0.3257 REMARK 3 19 1.8853 - 1.8520 0.69 2003 120 0.2399 0.2927 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.31 REMARK 3 B_SOL : 41.53 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.250 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.290 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 32.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.46 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 19.24590 REMARK 3 B22 (A**2) : -8.62200 REMARK 3 B33 (A**2) : -10.62390 REMARK 3 B12 (A**2) : -2.61130 REMARK 3 B13 (A**2) : -12.71460 REMARK 3 B23 (A**2) : 0.17910 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 5474 REMARK 3 ANGLE : 0.976 7444 REMARK 3 CHIRALITY : 0.064 792 REMARK 3 PLANARITY : 0.004 955 REMARK 3 DIHEDRAL : 19.888 2122 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4DBS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-JAN-12. REMARK 100 THE DEPOSITION ID IS D_1000070132. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-MAR-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X25 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : SAGITALLY FOCUSED SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 56673 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.08400 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.92 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.3 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.38400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1S2A REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.07 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.37 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15% PEG8000, 0.14 M SODIUM CHLORIDE, REMARK 280 0.1 M MES, PH 6.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ASP A 2 REMARK 465 SER A 3 REMARK 465 LYS A 4 REMARK 465 GLN A 5 REMARK 465 ASP A 321 REMARK 465 GLU A 322 REMARK 465 TYR A 323 REMARK 465 MET B 1 REMARK 465 ASP B 2 REMARK 465 SER B 3 REMARK 465 LYS B 4 REMARK 465 GLN B 5 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 197 74.97 -165.27 REMARK 500 SER A 221 171.22 77.36 REMARK 500 ARG A 250 -156.00 -128.04 REMARK 500 TYR A 319 32.84 -96.49 REMARK 500 SER B 51 -166.35 -128.89 REMARK 500 ASN B 57 10.34 -145.36 REMARK 500 PHE B 197 72.43 -153.35 REMARK 500 SER B 221 165.19 78.52 REMARK 500 ARG B 250 -157.60 -120.91 REMARK 500 ARG B 301 27.12 -144.77 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0HV A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0HV A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0HV B 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0HV B 403 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4DBU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE REMARK 900 5 (AKR1C3) IN COMPLEX WITH NADP+ AND 3-((4-(TRIFLUOROMETHYL)PHENYL) REMARK 900 AMINO)BENZOIC ACID REMARK 999 REMARK 999 SEQUENCE REMARK 999 H5Q IS A NATURAL VARIANT. DBREF 4DBS A 1 323 UNP P42330 AK1C3_HUMAN 1 323 DBREF 4DBS B 1 323 UNP P42330 AK1C3_HUMAN 1 323 SEQADV 4DBS GLN A 5 UNP P42330 HIS 5 SEE REMARK 999 SEQADV 4DBS GLN B 5 UNP P42330 HIS 5 SEE REMARK 999 SEQRES 1 A 323 MET ASP SER LYS GLN GLN CYS VAL LYS LEU ASN ASP GLY SEQRES 2 A 323 HIS PHE MET PRO VAL LEU GLY PHE GLY THR TYR ALA PRO SEQRES 3 A 323 PRO GLU VAL PRO ARG SER LYS ALA LEU GLU VAL THR LYS SEQRES 4 A 323 LEU ALA ILE GLU ALA GLY PHE ARG HIS ILE ASP SER ALA SEQRES 5 A 323 HIS LEU TYR ASN ASN GLU GLU GLN VAL GLY LEU ALA ILE SEQRES 6 A 323 ARG SER LYS ILE ALA ASP GLY SER VAL LYS ARG GLU ASP SEQRES 7 A 323 ILE PHE TYR THR SER LYS LEU TRP SER THR PHE HIS ARG SEQRES 8 A 323 PRO GLU LEU VAL ARG PRO ALA LEU GLU ASN SER LEU LYS SEQRES 9 A 323 LYS ALA GLN LEU ASP TYR VAL ASP LEU TYR LEU ILE HIS SEQRES 10 A 323 SER PRO MET SER LEU LYS PRO GLY GLU GLU LEU SER PRO SEQRES 11 A 323 THR ASP GLU ASN GLY LYS VAL ILE PHE ASP ILE VAL ASP SEQRES 12 A 323 LEU CYS THR THR TRP GLU ALA MET GLU LYS CYS LYS ASP SEQRES 13 A 323 ALA GLY LEU ALA LYS SER ILE GLY VAL SER ASN PHE ASN SEQRES 14 A 323 ARG ARG GLN LEU GLU MET ILE LEU ASN LYS PRO GLY LEU SEQRES 15 A 323 LYS TYR LYS PRO VAL CYS ASN GLN VAL GLU CYS HIS PRO SEQRES 16 A 323 TYR PHE ASN ARG SER LYS LEU LEU ASP PHE CYS LYS SER SEQRES 17 A 323 LYS ASP ILE VAL LEU VAL ALA TYR SER ALA LEU GLY SER SEQRES 18 A 323 GLN ARG ASP LYS ARG TRP VAL ASP PRO ASN SER PRO VAL SEQRES 19 A 323 LEU LEU GLU ASP PRO VAL LEU CYS ALA LEU ALA LYS LYS SEQRES 20 A 323 HIS LYS ARG THR PRO ALA LEU ILE ALA LEU ARG TYR GLN SEQRES 21 A 323 LEU GLN ARG GLY VAL VAL VAL LEU ALA LYS SER TYR ASN SEQRES 22 A 323 GLU GLN ARG ILE ARG GLN ASN VAL GLN VAL PHE GLU PHE SEQRES 23 A 323 GLN LEU THR ALA GLU ASP MET LYS ALA ILE ASP GLY LEU SEQRES 24 A 323 ASP ARG ASN LEU HIS TYR PHE ASN SER ASP SER PHE ALA SEQRES 25 A 323 SER HIS PRO ASN TYR PRO TYR SER ASP GLU TYR SEQRES 1 B 323 MET ASP SER LYS GLN GLN CYS VAL LYS LEU ASN ASP GLY SEQRES 2 B 323 HIS PHE MET PRO VAL LEU GLY PHE GLY THR TYR ALA PRO SEQRES 3 B 323 PRO GLU VAL PRO ARG SER LYS ALA LEU GLU VAL THR LYS SEQRES 4 B 323 LEU ALA ILE GLU ALA GLY PHE ARG HIS ILE ASP SER ALA SEQRES 5 B 323 HIS LEU TYR ASN ASN GLU GLU GLN VAL GLY LEU ALA ILE SEQRES 6 B 323 ARG SER LYS ILE ALA ASP GLY SER VAL LYS ARG GLU ASP SEQRES 7 B 323 ILE PHE TYR THR SER LYS LEU TRP SER THR PHE HIS ARG SEQRES 8 B 323 PRO GLU LEU VAL ARG PRO ALA LEU GLU ASN SER LEU LYS SEQRES 9 B 323 LYS ALA GLN LEU ASP TYR VAL ASP LEU TYR LEU ILE HIS SEQRES 10 B 323 SER PRO MET SER LEU LYS PRO GLY GLU GLU LEU SER PRO SEQRES 11 B 323 THR ASP GLU ASN GLY LYS VAL ILE PHE ASP ILE VAL ASP SEQRES 12 B 323 LEU CYS THR THR TRP GLU ALA MET GLU LYS CYS LYS ASP SEQRES 13 B 323 ALA GLY LEU ALA LYS SER ILE GLY VAL SER ASN PHE ASN SEQRES 14 B 323 ARG ARG GLN LEU GLU MET ILE LEU ASN LYS PRO GLY LEU SEQRES 15 B 323 LYS TYR LYS PRO VAL CYS ASN GLN VAL GLU CYS HIS PRO SEQRES 16 B 323 TYR PHE ASN ARG SER LYS LEU LEU ASP PHE CYS LYS SER SEQRES 17 B 323 LYS ASP ILE VAL LEU VAL ALA TYR SER ALA LEU GLY SER SEQRES 18 B 323 GLN ARG ASP LYS ARG TRP VAL ASP PRO ASN SER PRO VAL SEQRES 19 B 323 LEU LEU GLU ASP PRO VAL LEU CYS ALA LEU ALA LYS LYS SEQRES 20 B 323 HIS LYS ARG THR PRO ALA LEU ILE ALA LEU ARG TYR GLN SEQRES 21 B 323 LEU GLN ARG GLY VAL VAL VAL LEU ALA LYS SER TYR ASN SEQRES 22 B 323 GLU GLN ARG ILE ARG GLN ASN VAL GLN VAL PHE GLU PHE SEQRES 23 B 323 GLN LEU THR ALA GLU ASP MET LYS ALA ILE ASP GLY LEU SEQRES 24 B 323 ASP ARG ASN LEU HIS TYR PHE ASN SER ASP SER PHE ALA SEQRES 25 B 323 SER HIS PRO ASN TYR PRO TYR SER ASP GLU TYR HET NAP A 401 48 HET 0HV A 402 23 HET 0HV A 403 23 HET NAP B 401 48 HET 0HV B 402 23 HET 0HV B 403 23 HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETNAM 0HV 3-[(4-NITRONAPHTHALEN-1-YL)AMINO]BENZOIC ACID HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE FORMUL 3 NAP 2(C21 H28 N7 O17 P3) FORMUL 4 0HV 4(C17 H12 N2 O4) FORMUL 9 HOH *442(H2 O) HELIX 1 1 PRO A 30 GLY A 45 1 16 HELIX 2 2 ALA A 52 ASN A 56 5 5 HELIX 3 3 ASN A 57 ASP A 71 1 15 HELIX 4 4 LYS A 75 ILE A 79 5 5 HELIX 5 5 TRP A 86 HIS A 90 5 5 HELIX 6 6 ARG A 91 GLU A 93 5 3 HELIX 7 7 LEU A 94 ALA A 106 1 13 HELIX 8 8 ASP A 143 ALA A 157 1 15 HELIX 9 9 ASN A 169 ASN A 178 1 10 HELIX 10 10 ARG A 199 LYS A 209 1 11 HELIX 11 11 VAL A 234 GLU A 237 5 4 HELIX 12 12 ASP A 238 LYS A 249 1 12 HELIX 13 13 THR A 251 ARG A 263 1 13 HELIX 14 14 ASN A 273 VAL A 281 1 9 HELIX 15 15 GLN A 282 PHE A 286 5 5 HELIX 16 16 THR A 289 GLY A 298 1 10 HELIX 17 17 SER A 310 HIS A 314 5 5 HELIX 18 18 ARG B 31 GLY B 45 1 15 HELIX 19 19 ALA B 52 ASN B 56 5 5 HELIX 20 20 ASN B 57 ASP B 71 1 15 HELIX 21 21 LYS B 75 ILE B 79 5 5 HELIX 22 22 TRP B 86 HIS B 90 5 5 HELIX 23 23 ARG B 91 GLN B 107 1 17 HELIX 24 24 ASP B 143 ALA B 157 1 15 HELIX 25 25 ASN B 169 ASN B 178 1 10 HELIX 26 26 ARG B 199 LYS B 209 1 11 HELIX 27 27 VAL B 234 GLU B 237 5 4 HELIX 28 28 ASP B 238 LYS B 249 1 12 HELIX 29 29 THR B 251 ARG B 263 1 13 HELIX 30 30 ASN B 273 VAL B 281 1 9 HELIX 31 31 GLN B 282 PHE B 286 5 5 HELIX 32 32 THR B 289 GLY B 298 1 10 HELIX 33 33 SER B 310 HIS B 314 5 5 SHEET 1 A 2 CYS A 7 LYS A 9 0 SHEET 2 A 2 PHE A 15 PRO A 17 -1 O MET A 16 N VAL A 8 SHEET 1 B 9 LEU A 19 GLY A 22 0 SHEET 2 B 9 HIS A 48 ASP A 50 1 O HIS A 48 N PHE A 21 SHEET 3 B 9 PHE A 80 LEU A 85 1 O PHE A 80 N ILE A 49 SHEET 4 B 9 VAL A 111 ILE A 116 1 O LEU A 115 N LEU A 85 SHEET 5 B 9 ALA A 160 SER A 166 1 O LYS A 161 N VAL A 111 SHEET 6 B 9 CYS A 188 GLU A 192 1 O GLN A 190 N VAL A 165 SHEET 7 B 9 VAL A 212 TYR A 216 1 O VAL A 212 N ASN A 189 SHEET 8 B 9 VAL A 266 LYS A 270 1 O VAL A 266 N ALA A 215 SHEET 9 B 9 LEU A 19 GLY A 22 1 N GLY A 20 O VAL A 267 SHEET 1 C 2 CYS B 7 LYS B 9 0 SHEET 2 C 2 PHE B 15 PRO B 17 -1 O MET B 16 N VAL B 8 SHEET 1 D 9 LEU B 19 GLY B 22 0 SHEET 2 D 9 HIS B 48 ASP B 50 1 O ASP B 50 N PHE B 21 SHEET 3 D 9 PHE B 80 LEU B 85 1 O PHE B 80 N ILE B 49 SHEET 4 D 9 VAL B 111 ILE B 116 1 O LEU B 115 N LEU B 85 SHEET 5 D 9 ALA B 160 SER B 166 1 O LYS B 161 N VAL B 111 SHEET 6 D 9 CYS B 188 GLU B 192 1 O GLN B 190 N VAL B 165 SHEET 7 D 9 VAL B 212 TYR B 216 1 O VAL B 212 N ASN B 189 SHEET 8 D 9 VAL B 266 LYS B 270 1 O VAL B 266 N ALA B 215 SHEET 9 D 9 LEU B 19 GLY B 22 1 N GLY B 20 O VAL B 267 SITE 1 AC1 32 GLY A 22 THR A 23 TYR A 24 ASP A 50 SITE 2 AC1 32 TYR A 55 HIS A 117 SER A 166 ASN A 167 SITE 3 AC1 32 GLN A 190 TYR A 216 SER A 217 ALA A 218 SITE 4 AC1 32 LEU A 219 GLY A 220 SER A 221 GLN A 222 SITE 5 AC1 32 ALA A 253 LEU A 268 ALA A 269 LYS A 270 SITE 6 AC1 32 SER A 271 TYR A 272 ARG A 276 GLN A 279 SITE 7 AC1 32 ASN A 280 0HV A 402 HOH A1001 HOH A1023 SITE 8 AC1 32 HOH A1027 HOH A1122 HOH A1186 HOH A1208 SITE 1 AC2 12 TYR A 55 HIS A 117 MET A 120 ASN A 167 SITE 2 AC2 12 TYR A 216 TRP A 227 PHE A 306 PRO A 318 SITE 3 AC2 12 TYR A 319 NAP A 401 0HV A 403 HOH A1027 SITE 1 AC3 12 LEU A 54 TRP A 86 HIS A 117 SER A 118 SITE 2 AC3 12 MET A 120 SER A 129 ASN A 167 TRP A 227 SITE 3 AC3 12 PHE A 311 0HV A 402 HOH A1114 HOH A1258 SITE 1 AC4 36 GLY B 22 THR B 23 TYR B 24 ASP B 50 SITE 2 AC4 36 TYR B 55 HIS B 117 SER B 166 ASN B 167 SITE 3 AC4 36 GLN B 190 TYR B 216 SER B 217 ALA B 218 SITE 4 AC4 36 LEU B 219 GLY B 220 SER B 221 GLN B 222 SITE 5 AC4 36 ALA B 253 LEU B 268 ALA B 269 LYS B 270 SITE 6 AC4 36 SER B 271 TYR B 272 ASN B 273 ARG B 276 SITE 7 AC4 36 GLN B 279 ASN B 280 0HV B 402 0HV B 403 SITE 8 AC4 36 HOH B1003 HOH B1015 HOH B1041 HOH B1056 SITE 9 AC4 36 HOH B1077 HOH B1098 HOH B1110 HOH B1136 SITE 1 AC5 10 TYR B 55 HIS B 117 ASN B 167 TYR B 216 SITE 2 AC5 10 TRP B 227 PHE B 306 TYR B 319 NAP B 401 SITE 3 AC5 10 0HV B 403 HOH B1041 SITE 1 AC6 13 LEU B 54 TRP B 86 HIS B 117 SER B 118 SITE 2 AC6 13 MET B 120 LEU B 128 SER B 129 ASN B 167 SITE 3 AC6 13 TRP B 227 PHE B 311 NAP B 401 0HV B 402 SITE 4 AC6 13 HOH B1157 CRYST1 47.165 48.999 83.560 74.42 87.37 70.18 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021202 -0.007642 0.001125 0.00000 SCALE2 0.000000 0.021694 -0.006065 0.00000 SCALE3 0.000000 0.000000 0.012439 0.00000